|
|
적색스테인
|
|
 |
WtRRZgjdFQWrnGK |
 |
400 |
|
 |
| A jiffy bag http://imagefap.in.net/ fap pics Dr. Alexander Eggermont, chief executive of Institut Gustave-Roussy, France's largest cancer center, was one of those who held a hard line on Zelboraf testing, insisting on a randomized trial. But Eggermont now says the standard of proof has changed and he believes immunotherapies - which he calls the "biggest game changer we have ever seen" - will cement the new approach to testing. |
|
 |
Teodoro |
 |
2019-06-05 16:36:14 |
|
|
|
|
|
|
|
|
|
